Literature DB >> 1656698

Insulin-like growth factor receptors.

E K Neely1, M W Beukers, Y Oh, P Cohen, R G Rosenfeld.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1656698     DOI： 10.1111/j.1651-2227.1991.tb17985.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN： 0300-8843


× No keyword cloud information.
  7 in total

Review 1.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

2.  Histochemical analysis of insulin-like growth factor-1 binding sites in mouse normal and experimentally induced arthritic articular cartilage.

Authors:  P J Verschure; J Van Marle; L A Joosten; W B Van Den Berg
Journal:  Histochem J       Date:  1996-01

Review 3.  IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth.

Authors:  Y Oh
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis.

Authors:  P J Verschure; J van Marle; L A Joosten; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

Review 5.  Abnormal T-Cell Development in the Thymus of Non-obese Diabetic Mice: Possible Relationship With the Pathogenesis of Type 1 Autoimmune Diabetes.

Authors:  Daniella A Mendes-da-Cruz; Julia P Lemos; Geraldo A Passos; Wilson Savino
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-12       Impact factor: 5.555

6.  Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.

Authors:  H Wex; P Vorwerk; K Mohnike; D Bretschneider; U Kluba; V Aumann; W F Blum; U Mittler
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

7.  Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?

Authors:  Ioannis Protopsaltis; Achilles Ploumidis; Theodoros N Sergentanis; Padelis Constantoulakis; Kostantinos Tzirogiannis; Chrysoula Kyprianidou; Athanasia K Papazafiropoulou; Andreas Melidonis; Dimitrios Delakas
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.